Cargando…

Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection

Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (MTB), is a serious infectious disease with high infection and mortality rates and is a public health problem around the world. According to the World Health Organization (WHO) report, one-third of the world's population is latent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Yun-Jeong, Park, Heechul, Park, Sung-Bae, Kim, Junseong, Lee, Jiyoung, Kim, Jungho, Park, Sunyoung, Lee, Yong Sung, Kim, Sunghyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262775/ https://www.ncbi.nlm.nih.gov/pubmed/34278005 http://dx.doi.org/10.1016/j.jctube.2021.100253

Ejemplares similares

High Procalcitonin, C-Reactive Protein, and α-1 Acid Glycoprotein Levels in Whole Blood Samples Could Help Rapid Discrimination of Active Tuberculosis from Latent Tuberculosis Infection and Healthy Individuals
por: Kang, Yun-Jeong, et al.
Publicado: (2022)

Cytokine and Chemokine mRNA Expressions after Mycobacterium tuberculosis-Specific Antigen Stimulation in Whole Blood from Hemodialysis Patients with Latent Tuberculosis Infection
por: Park, Ji Young, et al.
Publicado: (2021)

Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection
por: Park, Heechul, et al.
Publicado: (2022)

Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis
por: Kim, Junseong, et al.
Publicado: (2022)

Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents
por: Kim, Kyeong-Hee, et al.
Publicado: (2011)

Prevalence and risk factors of latent tuberculosis among Korean healthcare workers using whole-blood interferon-γ release assay
por: Yeon, Jeong Hwa, et al.
Publicado: (2018)

Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population
por: Lee, Seung Heon, et al.
Publicado: (2015)

The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South Korea
por: Jang, Ju Young, et al.
Publicado: (2014)

Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
por: Doan, Tan N., et al.
Publicado: (2017)

Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay
por: Lee, Hyun, et al.
Publicado: (2019)

Arneth Blood Count in Tuberculosis
Publicado: (1913)

Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort
por: Kim, Hyung Woo, et al.
Publicado: (2021)

Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?
por: Jung, Jaewan, et al.
Publicado: (2021)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection
por: Huaman, Moises A., et al.
Publicado: (2016)

Comparison of the Tuberculin Skin Test and Interferon Gamma Release Assay for the Screening of Tuberculosis in Adolescents in Close Contact with Tuberculosis TB Patients
por: Song, Seung-Eun, et al.
Publicado: (2014)

Serum proteomic analysis of Mycobacterium tuberculosis antigens for discriminating active tuberculosis from latent infection
por: Peng, Zhangli, et al.
Publicado: (2020)

The blood transcriptional signature for active and latent tuberculosis
por: Deng, Min, et al.
Publicado: (2019)

Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children
por: Yun, Ki Wook, et al.
Publicado: (2016)

Diagnostic Potential of IgG and IgA Responses to Mycobacterium tuberculosis Antigens for Discrimination among Active Tuberculosis, Latent Tuberculosis Infection, and Non-Infected Individuals
por: Lee, Ji Yeon, et al.
Publicado: (2020)

Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis
por: Qiu, Xia, et al.
Publicado: (2019)

Evaluation of a New Chemiluminescent Immunoassay-Based Interferon-Gamma Release Assay for Detection of Latent Tuberculosis Infection
por: Kim, Keun Ju, et al.
Publicado: (2023)

Tuberculosis diagnosis: algorithm that May discriminate latent from active tuberculosis
por: Ndzi, Elvis Ndukong, et al.
Publicado: (2019)

The value of interferon-gamma blood tests for the diagnosis of tuberculosis in HIV patients
por: Căliman-Sturdza, Olga Adriana, et al.
Publicado: (2013)

Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012)

Tuberculosis Infection and Latent Tuberculosis
por: Lee, Seung Heon
Publicado: (2016)

Whole Blood Interferon-γ Release Assay Is Insufficient for the Diagnosis of Sputum Smear Negative Pulmonary Tuberculosis
por: Park, HeeJin, et al.
Publicado: (2014)

Household tuberculosis contact investigation in a tuberculosis-prevalent country: Are the tuberculin skin test and interferon-gamma release assay enough in elderly contacts?
por: Eom, Jung Seop, et al.
Publicado: (2018)

Comparing tuberculin skin test and interferon γ release assay (T-SPOT.TB) to diagnose latent tuberculosis infection in household contacts
por: Lee, Hyun Woo, et al.
Publicado: (2017)

Blood eosinophil count as a prognostic biomarker in COPD
por: Oh, Yeon-Mok, et al.
Publicado: (2018)

P1556: EVALUATION OF THE USEFULNESS OF INTERFERON-GAMMA RELEASE ASSAY FOR THE DETECTION OF LATENT MYCOBACTERIUM TUBERCULOSIS INFECTIONS IN PATIENTS WHO UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Lee, Yoengjoon, et al.
Publicado: (2023)

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay
por: Dewan, Puneet Kumar, et al.
Publicado: (2006)

Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis
por: Park, Youngmok, et al.
Publicado: (2018)

The Usefulness of Interferon-gamma Release Assay for Diagnosis of Tuberculosis-related Uveitis in Korea
por: Ahn, Seong Joon, et al.
Publicado: (2014)

Whole Blood Interferon-Gamma Responses to Mycobacterium tuberculosis Antigens in Young Household Contacts of Persons with Tuberculosis in Uganda
por: Lewinsohn, Deborah A., et al.
Publicado: (2008)

Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea
por: Jeon, Se-Mi, et al.
Publicado: (2023)

A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea
por: Park, Sun Hyo, et al.
Publicado: (2016)

Whole blood mRNA expression-based targets to discriminate active tuberculosis from latent infection and other pulmonary diseases
por: Petrilli, Jéssica D., et al.
Publicado: (2020)

Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection
por: Lee, Eun Hye, et al.
Publicado: (2017)

Levels of Interferon-Gamma Increase after Treatment for Latent Tuberculosis Infection in a High-Transmission Setting
por: Takenami, Iukary, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_88vpn4cg877k2qilmk4mi0uvgc